These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 27663089)

  • 1. Free microRNA levels in plasma distinguish T-cell mediated rejection from stable graft function after kidney transplantation.
    Matz M; Lorkowski C; Fabritius K; Durek P; Wu K; Rudolph B; Neumayer HH; Mashreghi MF; Budde K
    Transpl Immunol; 2016 Nov; 39():52-59. PubMed ID: 27663089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The selective biomarker IL-8 identifies IFTA after kidney transplantation in blood cells.
    Matz M; Lorkowski C; Fabritius K; Wu K; Rudolph B; Frischbutter S; Brakemeier S; Gaedeke J; Neumayer HH; Mashreghi MF; Budde K
    Transpl Immunol; 2016 Nov; 39():18-24. PubMed ID: 27693310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of T Cell-Mediated Vascular Rejection After Kidney Transplantation by the Combined Measurement of 5 Specific MicroRNAs in Blood.
    Matz M; Fabritius K; Lorkowski C; Dürr M; Gaedeke J; Durek P; Grün JR; Goestemeyer A; Bachmann F; Wu K; Rudolph B; Schmidt D; Weber U; Haftmann C; Unterwalder N; Lachmann N; Radbruch A; Neumayer HH; Mashreghi MF; Budde K
    Transplantation; 2016 Apr; 100(4):898-907. PubMed ID: 26444957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA regulation in blood cells of renal transplanted patients with interstitial fibrosis/tubular atrophy and antibody-mediated rejection.
    Matz M; Heinrich F; Lorkowski C; Wu K; Klotsche J; Zhang Q; Lachmann N; Durek P; Budde K; Mashreghi MF
    PLoS One; 2018; 13(8):e0201925. PubMed ID: 30102719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients.
    Halloran PF; Chang J; Famulski K; Hidalgo LG; Salazar ID; Merino Lopez M; Matas A; Picton M; de Freitas D; Bromberg J; Serón D; Sellarés J; Einecke G; Reeve J
    J Am Soc Nephrol; 2015 Jul; 26(7):1711-20. PubMed ID: 25377077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies.
    Halloran PF; Reeve JP; Pereira AB; Hidalgo LG; Famulski KS
    Kidney Int; 2014 Feb; 85(2):258-64. PubMed ID: 23965521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulated Expression of Circulating MicroRNAs in Kidney Transplant Recipients With Interstitial Fibrosis and Tubular Atrophy.
    Zununi Vahed S; Poursadegh Zonouzi A; Ghanbarian H; Ghojazadeh M; Samadi N; Ardalan M
    Iran J Kidney Dis; 2017 Jul; 11(4):309-318. PubMed ID: 28794294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulation of interferon type I pathway-related genes RSAD2 and ETV7 specifically indicates antibody-mediated rejection after kidney transplantation.
    Matz M; Heinrich F; Zhang Q; Lorkowski C; Seelow E; Wu K; Lachmann N; Addo RK; Durek P; Mashreghi MF; Budde K
    Clin Transplant; 2018 Dec; 32(12):e13429. PubMed ID: 30341925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristic changes in blood routine and peripheral blood lymphocyte subpopulations in recipients of different types of rejection.
    Luo S; Nie M; Song L; Xie Y; Zhong M; Tan S; An R; Li P; Tan L; Xie X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 49(3):417-425. PubMed ID: 38970516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.
    Yazdani S; Callemeyn J; Gazut S; Lerut E; de Loor H; Wevers M; Heylen L; Saison C; Koenig A; Thaunat O; Thorrez L; Kuypers D; Sprangers B; Noël LH; Van Lommel L; Schuit F; Essig M; Gwinner W; Anglicheau D; Marquet P; Naesens M
    Kidney Int; 2019 Jan; 95(1):188-198. PubMed ID: 30396694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of microRNA 142-3p in the peripheral blood and urinary cells of kidney transplant recipients with post-transplant graft dysfunction.
    Domenico TD; Joelsons G; Montenegro RM; Manfro RC
    Braz J Med Biol Res; 2017 Apr; 50(4):e5533. PubMed ID: 28380212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of circulating miR-21, miR-142-3p and miR-155 in renal transplant recipients with impaired graft function.
    Zununi Vahed S; Poursadegh Zonouzi A; Ghanbarian H; Ghojazadeh M; Samadi N; Omidi Y; Ardalan M
    Int Urol Nephrol; 2017 Sep; 49(9):1681-1689. PubMed ID: 28455659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue miRNA Profile Is Associated with Acute Tubular Necrosis, Rejection Phenotypes and BK Polyomavirus-Associated Nephropathy in Human Kidney Allografts.
    Bezeljak N; Kojc N; Arnol M; Večerić-Haler Ž; Boštjančič E
    Nephron; 2024; 148(5):300-311. PubMed ID: 37906981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Spectrum of Renal Allograft Failure.
    Chand S; Atkinson D; Collins C; Briggs D; Ball S; Sharif A; Skordilis K; Vydianath B; Neil D; Borrows R
    PLoS One; 2016; 11(9):e0162278. PubMed ID: 27649571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression patterns of B cells in acute kidney transplant rejection.
    Carpio VN; Noronha Ide L; Martins HL; Jobim LF; Gil BC; Külzer AS; Loreto Mda S; Gonçalves LF; Manfro RC; Veronese FV
    Exp Clin Transplant; 2014 Oct; 12(5):405-14. PubMed ID: 25299368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-free microRNA-148a is associated with renal allograft dysfunction: Implication for biomarker discovery.
    Nariman-Saleh-Fam Z; Bastami M; Ardalan M; Sharifi S; Hosseinian Khatib SM; Zununi Vahed S
    J Cell Biochem; 2019 Apr; 120(4):5737-5746. PubMed ID: 30320905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of microRNAs in renal transplant patients with acute T-cell mediated rejection.
    Soltaninejad E; Nicknam MH; Nafar M; Ahmadpoor P; Pourrezagholi F; Sharbafi MH; Hosseinzadeh M; Foroughi F; Yekaninejad MS; Bahrami T; Sharif-Paghaleh E; Amirzargar A
    Transpl Immunol; 2015 Sep; 33(1):1-6. PubMed ID: 26002284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miR-150, miR-192, miR-200b, and miR-423-3p as Non-invasive Biomarkers of Chronic Allograft Dysfunction.
    Zununi Vahed S; Poursadegh Zonouzi A; Mahmoodpoor F; Samadi N; Ardalan M; Omidi Y
    Arch Med Res; 2017 Jan; 48(1):96-104. PubMed ID: 28577875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary miR-155-5p and CXCL10 as prognostic and predictive biomarkers of rejection, graft outcome and treatment response in kidney transplantation.
    Millán O; Budde K; Sommerer C; Aliart I; Rissling O; Bardaji B; Matz M; Zeier M; Silva I; Guirado L; Brunet M
    Br J Clin Pharmacol; 2017 Dec; 83(12):2636-2650. PubMed ID: 28880456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
    Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
    J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.